In 2015, Mylan made a $29 billion unsolicited bid to acquire Perrigo (NYSE: PRGO ). This offer was later raised to a whopping$34 billion, and yet Perrigo, under then-CEO Joseph Papa, rejected the bid, claiming it “About the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curated research material. For investors requ ...